Go offline with the Player FM app!
Ep. 8: “Veterinary Virology” Featuring Dr. Robyn Hall
Manage episode 296885832 series 2895470
Guests:
Dr. Robyn Hall is a Research Scientist and Team Leader at the Commonwealth Scientific and Industrial Research Organisation. She is a veterinary virologist whose research focuses on innovative and applied solutions for improving rabbit biocontrol using rabbit caliciviruses.
Featured Products and Resources:
The Immunology Science Round Up
Coordinating an Antimicrobial Response in Leprosy – In addition to immune cells, cell types such as fibroblasts and keratinocytes can produce antimicrobial molecules in leprosy granulomas.
Modifying RNA Splicing to Enhance Immune Recognition – Scientists used drugs that modulate splicing to induce cancer cells to produce abnormal proteins, fostering recognition by immune cells.
Remodeling the Lymphoid Landscape – Researchers characterized three distinct subsets of lymphoid stromal cells in tonsil tissue and studied their reprogramming in follicular lymphoma.
A One-Two Punch of Immunotherapies – Researchers found that cancer patients who do not respond well to checkpoint inhibition may respond better to drugs that deplete T follicular regulatory cells prior to anti-PD1 therapy.
Photo Reference: Courtesy of Dr. Robyn Hall
108 episodes
Manage episode 296885832 series 2895470
Guests:
Dr. Robyn Hall is a Research Scientist and Team Leader at the Commonwealth Scientific and Industrial Research Organisation. She is a veterinary virologist whose research focuses on innovative and applied solutions for improving rabbit biocontrol using rabbit caliciviruses.
Featured Products and Resources:
The Immunology Science Round Up
Coordinating an Antimicrobial Response in Leprosy – In addition to immune cells, cell types such as fibroblasts and keratinocytes can produce antimicrobial molecules in leprosy granulomas.
Modifying RNA Splicing to Enhance Immune Recognition – Scientists used drugs that modulate splicing to induce cancer cells to produce abnormal proteins, fostering recognition by immune cells.
Remodeling the Lymphoid Landscape – Researchers characterized three distinct subsets of lymphoid stromal cells in tonsil tissue and studied their reprogramming in follicular lymphoma.
A One-Two Punch of Immunotherapies – Researchers found that cancer patients who do not respond well to checkpoint inhibition may respond better to drugs that deplete T follicular regulatory cells prior to anti-PD1 therapy.
Photo Reference: Courtesy of Dr. Robyn Hall
108 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.